Cargando…
Linezolid-induced pure red cell aplasia: a case report and literature review
Linezolid (LZD) is the first oxazolidinone with excellent safety and efficacy profiles against refractory infections caused by gram-positive organisms. Hematological toxicities such as thrombocytopenia, anemia, and leukocytopenia are common in LZD therapy; however, LZD-induced pure red cell aplasia...
Autores principales: | Luo, Zhuanbo, Xu, Ning, Wang, Yun, Huang, Xiaoping, Cao, Chao, Chen, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259366/ https://www.ncbi.nlm.nih.gov/pubmed/30270705 http://dx.doi.org/10.1177/0300060518800126 |
Ejemplares similares
-
Linezolid-Induced Pure Red Cell Aplasia: A Case Report
por: Yang, Xiao-Yan, et al.
Publicado: (2022) -
TKI-induced pure red cell aplasia: first case report of pure red cell aplasia with both imatinib and nilotinib
por: Poudyal, Bishesh Sharma, et al.
Publicado: (2016) -
Lenalidomide-Induced Pure Red Cell Aplasia
por: Dolai, Tuphan Kanti, et al.
Publicado: (2014) -
Emtricitabine-induced pure red cell aplasia
por: Manickchund, Nithendra, et al.
Publicado: (2019) -
Erythropoietin‐induced pure red cell aplasia
por: Yeung, Vivian K. P.
Publicado: (2022)